Plato Data Intelligence.
Vertical Search & Ai.

Tag: Pharmaceutical

CIRC Announces 2023 Annual Results

HONG KONG, Apr 17, 2024 - (ACN Newswire) - China Isotope & Radiation Corporation (“CIRC” or the “Company” , together with its subsidiaries, the “Group”;...

Top News

GTN, Exness, Saxo Bank and More: Executive Moves of the Week

This week noted a minor decrease in executive appointments within the forex, crypto, and fintech sectors, indicating a slight drop in industry moves.In recent...

Exness’ Chief Administrative Officer Elena Krutova Joins Global Pharmaceutical Firm

Elena Krutova, the former Chief Administrative Officer at Exness, recently moved to Remedia as the Chief HR Officer. According to information about the company on LinkedIn,...

Psilocybin Clinical Trial Sponsored by Clairvoyant Therapeutics Reaches 90% Randomization

Vancouver, BC, Apr 3, 2024 - (ACN Newswire) - Clairvoyant Therapeutics Inc. (www.clairvoyantrx.com), the private clinical-stage pharmaceutical company developing psilocybin treatment for alcohol use disorder...

French Sales Subsidiary Eisai S.A.S. to Divest Rights for Loxapac And Parkinane LP to CNX Therapeutics

Eisai Co., Ltd. announced today that its French sales subsidiary Eisai S.A.S. entered into an agreement to transfer the rights in France, the French...

CMS and Incyte Announce Collaboration and License Agreement for Povorcitinib in China and Southeast Asia

HONG KONG, China and WILMINGTON, Del., Apr 1, 2024 - (ACN Newswire) - China Medical System Holdings Limited (“CMS” or the “Group”) and Incyte (Nasdaq:INCY)...

Eisai to Divest Rights for Merislon and Myonal in Japan to Kaken Pharmaceutical

TOKYO, Mar 29, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that it has entered into an agreement to divest its rights...

Discovery Research on Dual Orexin Receptor Antagonist Lemborexant Honored with PSJ Award for Drug Research and Development 2024

TOKYO, Mar 29, 2024 - (JCN Newswire) - Eisai Co., Ltd. announced today that drug discovery research conducted on lemborexant (brand name: Dayvigo), the...

Sino Biopharm (1177.HK) Announces 2023 Annual Results

HONG KONG, Mar 29, 2024 - (ACN Newswire) - Sino Biopharmaceutical Limited (“Sino Biopharm” or the “Company”, together with its subsidiaries, the “Group”) (HKEX:1177), a...

HKbitEX Receives Provisional Approval for Virtual Asset Trading Platform License in Hong Kong

HKbitEX, a subsidiary of Tykhe Capital, has been granted a Type 1 regulated activity license and a Type 7 regulated activity license for its...

Financial Institutions Can Now Profit from over $1.5 Billion of Global Affiliate Spend

Companies offering in-app payments and financial services within their respective platforms are examples of applying embedded finance in non-financial services. As embedded finance alters how...

5 trends these AI experts think could change payments and commerce

For businesses at the forefront of their industries, artificial intelligence (AI) has...

Lifenet and Eisai Co-Develop Dementia Insurance “be”

TOKYO, Mar 21, 2024 - (JCN Newswire) - LIFENET INSURANCE COMPANY and Eisai Co., Ltd. announced today that they have co-developed Dementia Insurance “be”,...

Latest Intelligence

spot_img
spot_img
spot_img

Chat with us

Hi there! How can I help you?